AU5802000A - Medicinal substance utilization for preventing nitrate tolerance - Google Patents

Medicinal substance utilization for preventing nitrate tolerance

Info

Publication number
AU5802000A
AU5802000A AU58020/00A AU5802000A AU5802000A AU 5802000 A AU5802000 A AU 5802000A AU 58020/00 A AU58020/00 A AU 58020/00A AU 5802000 A AU5802000 A AU 5802000A AU 5802000 A AU5802000 A AU 5802000A
Authority
AU
Australia
Prior art keywords
medicinal substance
nitrate tolerance
substance utilization
preventing
preventing nitrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58020/00A
Other languages
English (en)
Inventor
Eberhard Bassenge
Gerd Konig
Michael Stoeter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Puren Pharma GmbH and Co KG
Original Assignee
Alpharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharma GmbH and Co KG filed Critical Alpharma GmbH and Co KG
Publication of AU5802000A publication Critical patent/AU5802000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU58020/00A 1999-05-05 2000-05-05 Medicinal substance utilization for preventing nitrate tolerance Abandoned AU5802000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19920775 1999-05-05
DE19920775A DE19920775A1 (de) 1999-05-05 1999-05-05 Arzneistoffverwendung zur Vermeidung von Nitrattoleranz
PCT/DE2000/001413 WO2000067731A2 (de) 1999-05-05 2000-05-05 Arzneistoffverwendung zur vermeidung von nitrattoleranz

Publications (1)

Publication Number Publication Date
AU5802000A true AU5802000A (en) 2000-11-21

Family

ID=7907118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58020/00A Abandoned AU5802000A (en) 1999-05-05 2000-05-05 Medicinal substance utilization for preventing nitrate tolerance

Country Status (6)

Country Link
EP (1) EP1173214A2 (de)
AU (1) AU5802000A (de)
BG (1) BG105955A (de)
DE (1) DE19920775A1 (de)
PL (1) PL352024A1 (de)
WO (1) WO2000067731A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537992B2 (en) 2001-01-05 2003-03-25 John D. Parker Regulation of organic nitrate tolerance
GB0909243D0 (en) * 2009-05-29 2009-07-15 Univ Dundee Angina treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839826A1 (de) * 1988-11-25 1990-05-31 Henning Berlin Gmbh Alkali- und erdalkalisalze des oxipurinols in amorpher oder kristalliner form als mittel zur behandlung von hyperurikaemie und gicht

Also Published As

Publication number Publication date
WO2000067731A2 (de) 2000-11-16
BG105955A (bg) 2002-06-28
EP1173214A2 (de) 2002-01-23
DE19920775A1 (de) 2000-11-16
PL352024A1 (en) 2003-07-14
WO2000067731A3 (de) 2001-01-25

Similar Documents

Publication Publication Date Title
AU1071301A (en) Pharmaceutical compounds
AU5259100A (en) Medicament
AU2006601A (en) Medicament dispenser
AU2509901A (en) Medicament dispenser
AU1724301A (en) Hydrogel-driven layered drug dosage form
AU3263501A (en) Advanced containment system
AU1514401A (en) Medicament dispenser
AU3837300A (en) Remedies
AU1887401A (en) Medicinal composition
AU4328800A (en) Pharmaceutical formulation
GB9930079D0 (en) Medicaments
GB9930071D0 (en) Medicaments
AU1645700A (en) Oenothein medicaments
AU5722900A (en) Pharmaceutical compounds
IL148543A0 (en) Pharmaceutical carrier formulation
AU5802000A (en) Medicinal substance utilization for preventing nitrate tolerance
AU3839900A (en) Pharmaceutical formulation
AU4726299A (en) Drug dispenser
GB9930083D0 (en) Medicaments
GB9924990D0 (en) Medicaments
AU2461200A (en) Remedies
AU1752101A (en) Medicament cartridge
AU1388501A (en) Pharmaceutical formulation
AU5442401A (en) Absorbent medicinal articles
AU4504201A (en) Drug preparations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase